By Elsa Ohlen
Drugstore chain Walgreens Boots Alliance is nearing a deal to be bought by private-equity firm Sycamore for roughly $10 billion, a report says.
Walgreens stock rose 6.6% to $10.94 in premarket trading.
A deal price of between $11.30 and $11.40 a share in cash has been discussed and a deal could be reached as soon as Thursday, The Wall Street Journal reported late Monday, citing people familiar with the matter.
Walgreens didn't immediately respond to a request for comment early on Tuesday.
If Sycamore ends up completing the buyout it is expected to maintain the Walgreens U.S. retail business but sell or take public the remaining parts of the company, according to The Wall Street Journal.
Walgreens shares are down 51% over the last 12 months. The stock peaked a decade ago with a market value of more than $100 billion.
Write to Elsa Ohlen at elsa.ohlen@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 04, 2025 05:26 ET (10:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。